tiprankstipranks
Trending News
More News >
Optimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
PremiumRatingsOptimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
2M ago
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
Premium
Ratings
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
2M ago
Oncolytics price target lowered to C$5 from C$6 at RBC Capital
Premium
The Fly
Oncolytics price target lowered to C$5 from C$6 at RBC Capital
2M ago
Oncolytics reports Q4 EPS (10c) vs. (5c) last year
PremiumThe FlyOncolytics reports Q4 EPS (10c) vs. (5c) last year
2M ago
Oncolytics Biotech (ONCY) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Oncolytics Biotech (ONCY) Q4 Earnings Cheat Sheet
2M ago
Oncolytics Biotech to Discuss 2024 Financial Results and Operational Highlights
Premium
Company Announcements
Oncolytics Biotech to Discuss 2024 Financial Results and Operational Highlights
2M ago
Oncolytics making progress in 2025 with regulatory, clinical advancements
PremiumThe FlyOncolytics making progress in 2025 with regulatory, clinical advancements
2M ago
Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency
Premium
Company Announcements
Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency
3M ago
Oncolytics receives noncompliance notification from Nasdaq
Premium
The Fly
Oncolytics receives noncompliance notification from Nasdaq
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100